ArticleIn silico pharmacology2025

Molecular docking, pharmacological profiling, and MD simulations of glycolytic inhibitors targeting novel SARS CoV-2 main protease and spike protein.

Nikhil Kumar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.